Skip to content
Search

Latest Stories

First year of Pharmacy First – has it been a success?

It was an initiative launched to drive up services within community pharmacy, but data shows that pharmacists are struggling to meet consultation thresholds, says Adele Curran

First year of Pharmacy First – has it been a success?

Pharmacists are struggling to meet Pharmacy First consultation thresholds

iStock

By Adele Curran

We have just passed the first anniversary of Pharmacy First Services in England. The new initiative promised a new way to approach community care and much needed additional revenue opportunities for community pharmacies across England. We can now review a year’s worth of data to paint a clearer picture on whether the industry met or missed these opportunities.


You’ll remember that the NHS pledged £646 million into the Pharmacy First Service to cover the first two years. When analysing the data set, I am assuming that allowances would have been for the programme to get up and running in year one and that forecasts of support would have been weighted heavier into year two.

Analysing the data, I am estimating that payout to pharmacies within the first year of Pharmacy First sits at approx. £104,341,050. This means that only 16% of the total pledge figure will be paid. (Dec & Jan figures estimated)

While we can see the services were widely accepted among pharmacies across the UK, there were a number of concerns over the qualifying criteria, in particular the monthly threshold.

Many pharmacies throughout England were struggling to meet the consultation threshold of 20 consultations per month. There are many suggestions as to why pharmacies were struggling, some cited that the services were not promoted enough by the NHS, GPs not fully understanding it or even IT systems not set up to support it.

We saw these concerns play out last October, when the NHS decided not to up the level of consultations needed to 30 as initially planned. They did, however, up this in January to 25 consultations and plan to increase to 30 in March 2025.

The data proves these concerns were legitimate.

Graph showing Pharmacy First consultation thresholds and payouts over the past year

We can see trend of increasing thresholds and CP payouts over the past 12 months, while the percentage of pharmacies meeting the threshold and the total payout decreased.

Within the first three months of Pharmacy First Services going live (Feb 24 – April 24), there was an average of 8,250 pharmacies hitting the threshold of consultations. This average fell to 7,030 between May and end of July and fell further to an average of 4,847 between August and October.

At the same time, we can see the average count of pharmacies who missed the threshold growing throughout the year. The total missed threshold value since launch is £40,54,300, equalling an average of over £3.3m a month.

The number of consultations remains relatively stable, with a slight increase towards the end of the year. We are not seeing the type of growth here hoped for upon the start of this initiative.

As mentioned previously, many reasons for why this has happened have already been voiced.

It is hard to quantify what control community pharmacies have over this though, as it is a push service towards pharmacies.

The volume of patients coming through their doors is not within their control. Could it be that there is still a lack of awareness form patients on what is now available as a service within their community pharmacies? Is this a marketing issue? There has also been some suggestion that certain surgeries aren’t keen to encourage patients straight to the pharmacy. With criteria within the service operating on a referral basis it is clear that this could be a major factor in the inabilities to reach the thresholds and is something that may need further investigation.

If community pharmacies are unable to enhance consultations, they will continue to fall behind the acceptable threshold and it’s likely the data trends see throughout 2024, will repeat in 2025.

Pharmacy First Services offer patients a new level of care within their local community, but it is clear something isn’t quite working with the current offering. There is substantial money available for pharmacies who can solve this puzzle.



Adele Curran is the Chief Operations Officer at RWA Pharmacy

Pharmacists are struggling to meet Pharmacy First consultation thresholds

Adele Curran, Chief Operations Officer at RWA Pharmacy discussing Pharmacy First data

Adele West-Curran, Chief Operating Officer, RWA Pharmacy

More For You

National Insurance Contributions rise to 15%: What it means for community pharmacies

From April 2025, the Employers’ National Insurance Contributions will rise to 15%.

gettyimages

Understanding the changes to National Insurance Contributions

The Autumn statement from the Chancellor was brutal for employers to say the least. The employer's National Insurance Contributions (NIC) is estimated to cost businesses c£25bn per annum from April 2025 onwards.

We cover the main points here:

Keep ReadingShow less
Harry McQuillan, Chair, Numark

Harry McQuillan, Chair, Numark

Community Pharmacy: Key to Future Primary Care & Prevention

Community pharmacy has never been more vital, and at the same time never been under greater strain.

While our colleagues in Scotland and Wales secured a 6% funding uplift for 2024/25, England is still waiting for clarity. It’s a frustrating position for a sector that has proven time and again it can step up, deliver, and ease pressure on other parts of the NHS.

Keep ReadingShow less
Why community pharmacy must embrace private services
The range of private services offered by pharmacists is likely to grow exponentially over the coming years (gettyimages)

Future of community pharmacy: Be more private

Tariq Muhammad considers how community pharmacy must explore private services to help create a more sustainable future.

We know remuneration influences behaviour. If I have a construction company and I pay a bricklayer a fee per brick to supply and fit, I suspect he will source them from the cheapest supplier and lay as many bricks as he possibly can. If one day, I reduce the fee such that it barely covers the cost of the brick, at a time when bricks are in short supply and labour costs have gone up, oh and I take some money off him for the profit he made on bricks he supplied the previous year, I suspect he will tell me to stick my job where the sun doesn’t shine.

It may be a crude analogy, but it is pretty much what’s happened in community pharmacy over the last 20 years. The remuneration we get for dispensing does not cover the cost of providing the service. The reimbursement for the drugs does not cover the cost of the drugs. In fact, we make a loss on many items given all the clawbacks and supply shortages. Wages have gone up. And then each year the government claws back profit they say we’ve made, apparently!

Keep ReadingShow less
The Government must fund the pharmacy sector sufficiently to secure it’s future.
Currently, the number of pharmacies operating in England is at an almost twenty year low. (gettyimages)

Pharmacy is under severe strain, time for the government to back those who put patients first

"The new contract in England has to provide the injection of cash the pharmacy sector desperately requires" 

By Jeremy Meader

Healthcare is one of the most crucial sectors in the UK accounting for over £290 billion, around 10% of the GDP for the entire country.

Despite this, however, many businesses operating in the healthcare sector are currently in favour of an urgent cash injection from the government. The figures make for sobering reading with over 65% of pharmacies operating at a loss and a bleak forecast that one in six might shut their doors for good within the next year.

Jeremy Meader Chief Wholesale Officer Bestway Healthcare

Jeremy Meader is the Chief Wholesale Officer of Bestway Healthcare, overseeing brands such as Lexon, Wardles, and Bestway Medhub. Jeremy has over 25 years of experience in the UK pharmaceutical sector, and has worked in executive roles across the industry.
Keep ReadingShow less
Harry McQuillan reflects on his first year as chairman of Numark UK
Harry McQuillan, Numark UK Chairman

Reflections on my first year as Numark UK chairman

The lack of a stable, predictable funding framework remains a critical issue for pharmacies in England - Harry McQuillan

As I reflect on my first year as chairman of Numark, I am struck by the incredible progress we’ve made together and the exciting opportunities that lie ahead for community pharmacy. This milestone feels like the perfect moment to take stock of our achievements and look forward to the future.

Stepping into this role after 17 years as a chief executive was both exhilarating and, I’ll admit, a little daunting. However, any initial apprehension quickly faded thanks to the warm welcome and support from my fellow UK Board members, the exceptional Numark team, and our dedicated members. It’s this shared sense of purpose, supporting our members to deliver outstanding care to their communities that continues to inspire me every day.

Keep ReadingShow less